Ratio de margen de beneficio operativo
desde 2005
Cálculo
Amgen Inc., ratio de margen de beneficio operativo, tendencias a largo plazocálculo
| Ratio de margen de beneficio operativo | = | 100 | × | Resultado de explotación1 | ÷ | Venta de productos1 | |
|---|---|---|---|---|---|---|---|
| 31 dic 2024 | 22.66% | = | 100 | × | 7,258) | ÷ | 32,026) |
| 31 dic 2023 | 29.35% | = | 100 | × | 7,897) | ÷ | 26,910) |
| 31 dic 2022 | 38.57% | = | 100 | × | 9,566) | ÷ | 24,801) |
| 31 dic 2021 | 31.44% | = | 100 | × | 7,639) | ÷ | 24,297) |
| 31 dic 2020 | 37.70% | = | 100 | × | 9,139) | ÷ | 24,240) |
| 31 dic 2019 | 43.57% | = | 100 | × | 9,674) | ÷ | 22,204) |
| 31 dic 2018 | 45.55% | = | 100 | × | 10,263) | ÷ | 22,533) |
| 31 dic 2017 | 45.76% | = | 100 | × | 9,973) | ÷ | 21,795) |
| 31 dic 2016 | 44.74% | = | 100 | × | 9,794) | ÷ | 21,892) |
| 31 dic 2015 | 40.44% | = | 100 | × | 8,470) | ÷ | 20,944) |
| 31 dic 2014 | 32.03% | = | 100 | × | 6,191) | ÷ | 19,327) |
| 31 dic 2013 | 32.25% | = | 100 | × | 5,867) | ÷ | 18,192) |
| 31 dic 2012 | 33.52% | = | 100 | × | 5,577) | ÷ | 16,639) |
| 31 dic 2011 | 28.19% | = | 100 | × | 4,312) | ÷ | 15,295) |
| 31 dic 2010 | 37.82% | = | 100 | × | 5,545) | ÷ | 14,660) |
| 31 dic 2009 | 38.37% | = | 100 | × | 5,506) | ÷ | 14,351) |
| 31 dic 2008 | 35.50% | = | 100 | × | 5,214) | ÷ | 14,687) |
| 31 dic 2007 | 27.81% | = | 100 | × | 3,980) | ÷ | 14,311) |
| 31 dic 2006 | 27.71% | = | 100 | × | 3,840) | ÷ | 13,858) |
| 31 dic 2005 | 40.33% | = | 100 | × | 4,848) | ÷ | 12,022) |
Basado en los informes: 10-K (Fecha del informe: 2024-12-31), 10-K (Fecha del informe: 2023-12-31), 10-K (Fecha del informe: 2022-12-31), 10-K (Fecha del informe: 2021-12-31), 10-K (Fecha del informe: 2020-12-31), 10-K (Fecha del informe: 2019-12-31), 10-K (Fecha del informe: 2018-12-31), 10-K (Fecha del informe: 2017-12-31), 10-K (Fecha del informe: 2016-12-31), 10-K (Fecha del informe: 2015-12-31), 10-K (Fecha del informe: 2014-12-31), 10-K (Fecha del informe: 2013-12-31), 10-K (Fecha del informe: 2012-12-31), 10-K (Fecha del informe: 2011-12-31), 10-K (Fecha del informe: 2010-12-31), 10-K (Fecha del informe: 2009-12-31), 10-K (Fecha del informe: 2008-12-31), 10-K (Fecha del informe: 2007-12-31), 10-K (Fecha del informe: 2006-12-31), 10-K (Fecha del informe: 2005-12-31).
1 US$ en millones
Comparación con la competencia
Amgen Inc., ratio de margen de beneficio operativo, tendencias a largo plazo, comparación con los competidores
| Amgen Inc. | AbbVie Inc. | Danaher Corp. | Gilead Sciences Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | Vertex Pharmaceuticals Inc. | |
|---|---|---|---|---|---|---|---|
| 31 dic 2024 | 22.66% | 16.22% | 20.37% | 5.81% | 28.10% | 17.11% | -2.11% |
| 31 dic 2023 | 29.35% | 23.49% | 21.77% | 28.24% | 30.85% | 16.00% | 38.83% |
| 31 dic 2022 | 38.57% | 31.21% | 27.61% | 27.17% | 38.93% | 18.69% | 48.23% |
| 31 dic 2021 | 31.44% | 31.89% | 25.35% | 36.72% | 55.67% | 25.57% | 36.73% |
| 31 dic 2020 | 37.70% | 24.81% | 18.99% | 16.72% | 42.09% | 24.19% | 46.03% |
| 31 dic 2019 | 43.57% | 39.03% | 18.25% | 19.38% | 28.10% | 17.99% | 28.77% |
| 31 dic 2018 | 45.55% | 19.49% | 17.11% | 37.83% | 37.77% | 15.53% | 20.84% |
| 31 dic 2017 | 45.76% | 33.99% | 16.48% | 55.04% | 35.41% | 14.19% | 4.95% |
| 31 dic 2016 | 44.74% | 36.60% | 16.29% | 58.87% | 27.38% | 13.40% | 0.58% |
| 31 dic 2015 | 40.44% | 32.97% | 16.87% | 69.03% | 30.51% | 13.77% | -45.23% |
| 31 dic 2014 | 32.03% | 17.09% | 17.23% | 62.37% | 29.74% | 14.82% | -119.30% |
| 31 dic 2013 | 32.25% | 30.14% | 17.13% | 41.87% | 36.11% | 12.30% | -74.54% |
| 31 dic 2012 | 33.52% | 31.65% | 17.33% | 42.67% | 33.20% | 11.85% | 0.15% |
| 31 dic 2011 | 28.19% | — | 16.27% | 46.77% | -46.02% | 10.62% | 8.07% |
| 31 dic 2010 | 37.82% | — | 16.41% | 53.62% | -21.23% | 11.72% | -485.51% |
| 31 dic 2009 | 38.37% | — | 13.79% | 54.55% | -19.54% | 10.38% | -602.63% |
| 31 dic 2008 | 35.50% | — | 14.72% | 52.68% | -37.67% | 11.71% | -263.65% |
| 31 dic 2007 | 27.81% | — | 15.79% | 57.98% | -91.55% | 10.00% | -210.94% |
| 31 dic 2006 | 27.71% | — | 15.82% | -29.32% | -169.68% | 6.38% | -105.86% |
| 31 dic 2005 | 40.33% | — | 15.84% | 61.41% | -187.97% | 10.01% | -93.15% |
Basado en los informes: 10-K (Fecha del informe: 2024-12-31), 10-K (Fecha del informe: 2023-12-31), 10-K (Fecha del informe: 2022-12-31), 10-K (Fecha del informe: 2021-12-31), 10-K (Fecha del informe: 2020-12-31), 10-K (Fecha del informe: 2019-12-31), 10-K (Fecha del informe: 2018-12-31), 10-K (Fecha del informe: 2017-12-31), 10-K (Fecha del informe: 2016-12-31), 10-K (Fecha del informe: 2015-12-31), 10-K (Fecha del informe: 2014-12-31), 10-K (Fecha del informe: 2013-12-31), 10-K (Fecha del informe: 2012-12-31), 10-K (Fecha del informe: 2011-12-31), 10-K (Fecha del informe: 2010-12-31), 10-K (Fecha del informe: 2009-12-31), 10-K (Fecha del informe: 2008-12-31), 10-K (Fecha del informe: 2007-12-31), 10-K (Fecha del informe: 2006-12-31), 10-K (Fecha del informe: 2005-12-31).